Imagine a world where every lab, regardless of size or budget, has access to cutting-edge proteomics technology. Sounds like a distant dream, right? But here’s the game-changer: Olink is turning this vision into reality. At Olink, our unwavering mission has always been to democratize high-quality proteomics, ensuring it’s not just a privilege for a select few but a tool for all researchers. And today, we’re thrilled to announce a monumental leap forward: Olink® Reveal is now fully verified for sequencing on MGI T1+ and G400 sequencers, complete with optimized protocols and proven performance. Read more here.
This breakthrough isn’t just about compatibility—it’s about expanding the horizon of possibility. By enabling more labs to generate reliable, high-quality protein data through a streamlined NGS-based workflow, we’re empowering researchers to dive deeper into disease biology than ever before. And this is the part most people miss: with access to ~1,000 meticulously curated proteins, scientists can uncover actionable biological insights that could reshape our understanding of complex diseases. But here’s where it gets controversial: as proteomics becomes more accessible, will all labs be equipped to handle the flood of data? Or will this create a new divide between those who can interpret the insights and those who can’t?
This advancement is more than just a technical achievement—it’s a stride toward our bold vision of making high-quality proteomics accessible to every lab, everywhere. But we want to hear from you: Do you think widespread access to proteomics will level the playing field in research, or will it introduce new challenges? Share your thoughts in the comments below and let’s spark a conversation that could shape the future of science.
